Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Predictive Performance of a Target-controlled Infusion Model for the Administration of Cefepime to Intensive Care Patients

NCT02688582 is registered in ClinicalTrials.gov with Onze Lieve Vrouw Hospital as lead sponsor.

NCT NCT02688582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02688582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Predictive Performance of a Target-controlled Infusion Model for the Administration of Cefepime to Intensive Care Patients
Lead sponsor
Onze Lieve Vrouw Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2016
Completion date
February 28, 2019
Enrollment
21 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antimicrobial treatment